logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Dyson founder transfers 624 million in assets to Singapore

date
08/02/2026
James Dyson, the founder of Dyson company and the richest man in the UK, recently made significant adjustments to his family's wealth management structure. According to an analysis of company registration documents, the Dyson family's investment company, Weyburn, transferred at least 624 million from its UK main entity to a new Singapore holding company by 2025, leaving the UK entity with only 1 in book capital.
Latest
23 m ago
South African Reserve Bank Governor: South Africa is eager to receive the European Central Bank's new repo loan arrangement.
1 h ago
Su Yiming won the first medal for the Chinese delegation at the Milan Winter Olympics.
1 h ago
Insiders: The Federal Communications Commission is investigating whether the ABC program "Viewpoint" violated the equal time rule by interviewing a candidate for the Texas State Senate.
2 h ago
The CEO of American Airlines has agreed to meet with the Allied Pilots Association.
2 h ago
American telemedicine company Hims & Hers Health: Since launching its customized oral formulation of Sermorelin on its platform, the company has engaged in constructive communication with various stakeholders in the industry. The company has decided to discontinue providing services related to this therapy.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.